Merck Share Sale Reduces Commonwealth Stake to 5th Largest Position
Commonwealth Retirement Investments LLC has reduced its stake in Merck & Co., Inc. (NYSE:MRK), according to the company's latest Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor sold 10,599 shares during the second quarter, decreasing its holdings by 11.3%. This move left Commonwealth Retirement Investments LLC owning 83,307 shares of Merck & Co., Inc.'s stock.
The holding accounts for 2.9% of Commonwealth Retirement Investments LLC's portfolio, making it the company's 5th largest position. The value of these holdings is approximately $10,705,000 as per the SEC filing.
Other institutional investors and hedge funds have also been active in buying and selling Merck & Co., Inc. shares. Kingdom Financial Group LLC acquired a new stake in the company during the fourth quarter valued at $25,000. Abound Financial LLC purchased a new stake worth $26,000 in the same period.
Merck & Co., Inc.'s stock price has been impacted by various factors, including its recent quarterly earnings report and the success of its individualized mRNA vaccine in high-risk melanoma trials. Analysts have provided mixed views on the company's prospects, with some upgrading their target prices while others downgrading them.